article thumbnail

Retail Community Pharmacist Wages Declined from 2012 to 2022

Drug Topics

Researchers addressed the wage gaps in specific pharmacy settings in relation to big chain retail pharmacy mergers.

143
143
article thumbnail

340B program continues to drive shift in care to more expensive hospital settings

PhRMA

In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.

Hospitals 286
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

EC grants orphan drug designation for Precigen’s PRGN-2012

Pharmaceutical Technology

The EC has granted orphan drug designation (ODD) for Precigen's PRGN-2012 aimed at treating recurrent respiratory papillomatosis (RRP).

52
article thumbnail

Opioid Prescriptions for US Patients With Cancer, Non-Cancer Pain Falls, Study Results Show

Pharmacy Times

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.

122
122
article thumbnail

How Seth Rogen and Lauren Miller Rogen are using comedy to support Alzheimer’s care

STAT

Since 2012, comedian and filmmaker Lauren Miller Rogen and her husband, actor and comedian Seth Rogen, have used humor to help raise awareness for Alzheimer’s disease and funds for at-home caregiving through their nonprofit Hilarity for Charity. Alzheimer’s isn’t funny.

139
139
article thumbnail

Decline in heart failure deaths has been undone, led by people under 45

STAT

death certificate data from 1999 through 2021, revealing a steady drop in deaths until 2012, when rates plateaued, then began to rise steadily, and accelerated upward once the Covid-19 pandemic arrived. The concerning conclusion comes as newer medications are raising hopes for better outcomes in the years to come.

145
145
article thumbnail

J&J's tuberculosis med Sirturo lands full US, EU approvals after more than a decade on the market

Fierce Pharma

The traditional approvals follow initial accelerated approvals granted by the FDA in 2012 and the European Commission in 2014. It took many years, but Johnson & Johnson’s tuberculosis med Sirturo can finally claim full approvals in the U.S. and Europe following initial conditional nods. |

FDA 118